USCA RIA’s Ionis Pharmaceuticals IONS Stock Holding History

USCA RIA’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-3,500	Closed	-$223K	–	347
2015 Q1	$223K	Buy	+3,500	New	+$237K	0.06%	305

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

USCA RIA's IONS Position: Q2 2015 in Review

USCA RIA sold out of Ionis Pharmaceuticals (IONS) in Q2 2015, closing a stake of 3,500 shares — an estimated $223K sold.

USCA RIA first reported a position in IONS in Q1 2015 and held it in 1 quarter. The position peaked at $223K in Q1 2015. 353 funds tracked by Wall St. Rank hold IONS as of Q2 2015.

USCA RIA reported no remaining Ionis Pharmaceuticals position as of Q2 2015 after selling out during the quarter.
USCA RIA sold 3,500 Ionis Pharmaceuticals shares in Q2 2015, an estimated $223K.
USCA RIA first reported a position in Ionis Pharmaceuticals in Q1 2015 and held it in 1 quarter.
USCA RIA's Ionis Pharmaceuticals position peaked at $223K in Q1 2015.
353 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2015.

Based on USCA RIA's 13F filing for Q2 2015, filed 12 Aug 2015.